You are here

  • Home
  • Archive
  • Volume 9, Issue Suppl 2
  • 161 Anti-myeloid poly-pharmacy combined with FGFR4-targeted chimeric antigen receptors (CARs) effectively treats orthotopic rhabdomyosarcoma, modeling CAR effectiveness for solid tumors

Article metrics

Article menu

Download PDFPDF

Regular and Young Investigator Award Abstracts
Cellular Therapies
161 Anti-myeloid poly-pharmacy combined with FGFR4-targeted chimeric antigen receptors (CARs) effectively treats orthotopic rhabdomyosarcoma, modeling CAR effectiveness for solid tumors
Free

 

Online download statistics by month:

Online download statistics by month: November 2021 to November 2024

AbstractFullPdf
Nov 2021174018
Dec 202174012
Jan 20222608
Feb 20222202
Mar 202229004
Apr 20226805
May 202244013
Jun 20221202
Jul 20222604
Aug 20221601
Sep 20222007
Oct 20221804
Nov 20221004
Dec 20222000
Jan 20231804
Feb 20231201
Mar 20231600
Apr 2023600
May 20231201
Jun 2023605
Jul 2023407
Aug 2023402
Oct 2023803
Nov 202318010
Dec 20234602
Jan 20245006
Feb 20241602
Mar 20248015
Apr 20241608
May 20241601
Jun 2024801
Jul 202424010
Aug 2024204
Sep 2024802
Oct 202410010
Nov 20241004
Total11380182